N@N

Talecris Biotherapeutics to Present at the 28th Annual J.P. Morgan Healthcare Conference

^{Published on 2010-01-09 10:15:22 - Market Wire}
 

RESEARCH TRIANGLE PARK, N.C.--([ BUSINESS WIRE ])--Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced that Lawrence D. Stern, Chairman and Chief Executive Officer of Talecris, will present at the 28^th Annual J.P. Morgan Healthcare Conference at 8:30 a.m., Wednesday, Jan. 13 at the Westin St. Francis Hotel in San Francisco.

A live webcast of Talecris' presentation will be accessible through the investor relations section of the Talecris Web site, [ www.talecris.com/investor-relations.htm ]. A replay of the webcast will be available for 30 days following the presentation and can be accessed at the same Web address.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis.